<DOC>
	<DOCNO>NCT01667081</DOCNO>
	<brief_summary>This three-year ( except participant chronic kidney disease [ CKD ] cirrhosis ) multicenter study follow participant receive least one dose grazoprevir ( MK-5172 ) previous study determine whether remain hepatitis C virus ( HCV ) -RNA negative time , determine develop antiviral resistance . The study also evaluate long-term adverse event population . Participants MK-5172-052 ( NCT02092350 ) CKD cirrhosis follow five year . As Amendment 03 , study design revise continued enrollment participant fail prior therapy grazoprevir regimen . Participants CKD enrol MK-5172-052 ( NCT02092350 ) continue enrollment regardless prior treatment-response remain study five year , participant enrol study HCV RNA less low limit quantitation ( LLOQ ) discontinue end participation next scheduled visit . In addition , participant receive HCV treatment concurrent follow-up study receive HCV treatment prior study discontinue data exclude analysis .</brief_summary>
	<brief_title>Durability Virologic Response and/or Viral Resistance Patterns Participants With Chronic Hepatitis C Who Have Been Previously Treated With Grazoprevir ( MK-5172 ) ( MK-5172-017 )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<criteria>Previously participate HCV treatment protocol include grazoprevir treatment regimen . Must enroll present study within three month last study visit previous protocol receive grazoprevircontaining regimen . For Amendment 03 : Participants must receive grazoprevircontaining regimen prior trial identify failed therapy study . Has receive HCV therapy completion protocoldefined grazoprevir treatment trial regimen entry followup study For Amendment 03 : Has fail therapy due reinfection . For Amendment 03 : Has fail therapy receive retreatment HCV therapy , except case retreat Mercksponsored protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>